Literature DB >> 17466949

Hedgehog is involved in prostate basal cell hyperplasia formation and its progressing towards tumorigenesis.

Bo-Yie Chen1, Jer-Yuh Liu, Han-Hsin Chang, Chin-Pao Chang, Wei-Yuh Lo, Wu-Hsien Kuo, Chi-Rei Yang, David P C Lin.   

Abstract

The role of Hedgehog signaling in human basal cell hyperplasia formation and its progressing towards tumorigenesis was investigated. Hedgehog signaling members including PTCH1, GLI1, GLI2, and GLI3 were found co-localized with p63 expression in most hyperplastic basal cells, but rarely in normal basal cells, suggesting Hedgehog involvement in basal cell hyperplasia formation. Both CK-14 and CK-8 markers were found co-localized in the majority of hyperplastic basal cells, but relatively few in the normal basal cells, indicating a Hedgehog-promoted transitory differentiation. Furthermore, CK-14 and PTCH1 were found co-localized with CD44 in the hyerplastic basal cells, in a way similar to the CD44 co-localization with PTCH1 and GLI1 in the cancer cells. Together, the present study indicated Hedgehog involvement in forming basal cell hyperplasia and its progressing towards cancer, presumably by transforming the normal basal stem cells into the cancer stem cells where persistent Hedgehog activation might be mandatory for tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17466949     DOI: 10.1016/j.bbrc.2007.04.091

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

Review 1.  Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Aspects Med       Date:  2013-08-29

2.  Cytotoxic effects induced by docetaxel, gefitinib, and cyclopamine on side population and nonside population cell fractions from human invasive prostate cancer cells.

Authors:  Murielle Mimeault; Sonny L Johansson; Jean-Pierre Henichart; Patrick Depreux; Surinder K Batra
Journal:  Mol Cancer Ther       Date:  2010-02-23       Impact factor: 6.261

Review 3.  New promising drug targets in cancer- and metastasis-initiating cells.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Drug Discov Today       Date:  2010-03-23       Impact factor: 7.851

Review 4.  Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Med       Date:  2011-05-20       Impact factor: 6.354

Review 5.  Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Anticancer Agents Med Chem       Date:  2010-02       Impact factor: 2.505

6.  The GLI1 splice variant TGLI1 promotes glioblastoma angiogenesis and growth.

Authors:  Hu Zhu; Richard L Carpenter; Woody Han; Hui-Wen Lo
Journal:  Cancer Lett       Date:  2013-09-15       Impact factor: 8.679

7.  Congenital eye malformations associated with extensive periocular neural crest apoptosis after influenza B virus infection during early embryogenesis.

Authors:  Bo-Yie Chen; Han-Hsin Chang; Shyan-Tang Chen; Zih-Jay Tsao; Shang-Min Yeh; Chia-Yung Wu; David Pei-Cheng Lin
Journal:  Mol Vis       Date:  2009-12-19       Impact factor: 2.367

Review 8.  Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies.

Authors:  Murielle Mimeault; Parmender P Mehta; Ralph Hauke; Surinder K Batra
Journal:  Endocr Rev       Date:  2008-02-21       Impact factor: 19.871

9.  Robust expression of Prominin-2 all along the adult male reproductive system and urinary bladder.

Authors:  József Jászai; Christine A Fargeas; Michael Haase; Lilla M Farkas; Wieland B Huttner; Denis Corbeil
Journal:  Histochem Cell Biol       Date:  2008-06-07       Impact factor: 4.304

Review 10.  Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers.

Authors:  M Mimeault; S K Batra
Journal:  Panminerva Med       Date:  2008-03       Impact factor: 5.197

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.